Link: University of Iowa

research

Introducing Pediatric Research, A CTSA Sponsored Research Collaboratory

The Institute for Clinical and Translation Science has a new social networking website for pediatric researchers called Pediatric Research. Pediatric Research's goal is to enhance communication and collaboration among pediatric researchers at the University of Iowa Children's Hospital for the ultimate purpose of improving the health of pediatric patients and families.

National Institutes of Health (NIH) Research Portfolio Online Reporting Tool (RePORT)

NIH RePORTER

We're exciting to help spread the word about the new National Institutes of Health (NIH) Research Portfolio Online Reporting Tool (RePORT). This on-line resource provides instant access to important resources including reports, data, and analysis of NIH sponsored research activities, and offers useful information about NIH funding, expenditure, and results.

Additional Research Resources

Center for Biocatalysis and Bioprocessing (CBB)


The University of Iowa Center for Biocatalysis and Bioprocessing (CBB) collaborates yearly with more than 60 industrial companies and institutions to produce vaccines, antibiotics, anti-cancer drugs, polymers, BL2-LS pathogens, biochemicals, ensymes, pharmaceutical intermediates, and derivatives of bioactive compounds. The CBB is composed of a university-wide consortium using state-of-the-art facilities with the aim of providing world-class education and training, research and scholarship, as well as wide-ranging technology transfer activities in the real of biotechnology.

Schizophrenia Research at UI Receives $1.6 Million NIH Grant

University of Iowa research that aims to help improve treatments for schizophrenia has been funded by a two-year, $1.6 million grant from the National Institute of Mental Health, part of the National Institutes of Health. The grant is effective July 1.


The study focuses on the genetic basis of schizophrenia, which affects 1 percent of the world's population and likely accounts for most long-term disability in the United States.


"Our research focuses on identifying genetic abnormalities called copy number variations. This information eventually could help us determine which patients with schizophrenia would respond best to particular medications," said Tom Wassink, M.D., the study's principal investigator and associate professor of psychiatry and pediatrics at the UI Carver College of Medicine and UI Children's Hospital. "Currently, some patients respond well to certain drug therapies, while others do not."

Clinical and Translational Science Network Launched

The AAMC has partnered with the American Association for the Advancement of Science, Science Careers, and several other organizations to launch CTSciNET, the Clinical and Translational Science Network. CTSciNet is designed to assist clinicians interested in research, M.D.-Ph.D. trainees and recipients, Ph.D.-track scientists who want to work closer to the clinic, and anyone considering these career paths. The project is supported by the Burroughs Wellcome Fund.

For more Information

Syndicate content